Сannabidiol may fight Alzheimer's
( blocks the adenosine receptor )
Please Help Support Alzheimer's Research Today!
Your Alzheimer's donation will help billions live without it.
The compounds in the Cannabis plant can affect brain cells in different ways. For decades scientists have exploited these plant compounds for therapeutic uses. Last week, a recent research article on how a specific Cannabis compound may fight Alzheimer’s disease was presented at Temple University’s Cannabinoid Discussion Group meeting.
The research was conducted using Cannabidiol (CBD) which is the second most abundant cannabinoid found in theCannabis plant. CBD is not considered to be psychoactive, as the compound does not interact with any known cannabinoid receptors. Due to the medical properties of this compound, it has become of interest to medical cannabis patients.
The researchers used petri dish models of Alzheimer’s disease to demonstrate the effectiveness of CBD. The petri model simulated the effects of dead neurons by adding ATP, a compound which is released when brain cells die, to the petri dish. CBD was able to reduce ATP stimulated changes by as much as 25%. The authors also published data demonstrating how CBD can inhibit microglial cell activation, and thus inhibit this part of Alzheimer’s disease progression. Read more: examiner.com
Women know that folic acid is beneficial but not why
Ninety five per cent of New Zealand women have heard of folic acid, but only about a quarter of them know what the spinal defect-combating vitamin B form actually does, a survey has found. Read more: nutraingredients.com
No comments:
Post a Comment